Seeking Alpha Rates Sandisk a Buy on Contract Visibility; DeepValue Report Maintains Wait

What happened

Sandisk's latest Seeking Alpha article rates the stock a Buy, highlighting multi-year contracts worth $94 billion that secure over four years of demand and lock in minimum pricing and volume commitments for 50% of 2027 and two-thirds of 2028 chip sales. The article also notes a forward P/E of 8.07x, below sector median, and strong free cash flow and buyback momentum, despite the stock's 665% year-to-date return. However, the latest DeepValue master report maintains a WAIT rating, arguing that the stock at $1,599.6 already prices in a prolonged NAND shortage that external supply data does not support. The report acknowledges the value of the New Business Model agreements but points out that only 19% of remaining performance obligations convert within twelve months and that current earnings are heavily price-driven, with FQ4 growth roughly two-thirds from pricing. It also flags that TrendForce expects NAND supply growth to outpace demand in 2027, with easing in 2H27, which could compress margins toward contract floors.

Implication

The article's emphasis on contract coverage downplays the fact that only a small portion of the backlog is near-term revenue, and that margins are currently at cyclical highs. The forward P/E of 8.07x is based on peak earnings that may not be sustainable if supply growth accelerates. The master report's scenario analysis suggests a downside to $1,100 in a bear case where margins compress, which would erode a significant portion of recent gains. Conversely, if hyperscaler demand extends scarcity, the bull case of $1,850 remains possible, but the risk/reward at $1,599.6 is not compelling. Investors should wait for evidence of sustained margin above 83% and revenue beats before adding, and should monitor NAND supply data and customer capex commentary closely.

Thesis delta

No material thesis shift from the master report's WAIT rating. The article reinforces the existence of long-term contracts but does not address the key risk of price normalization. The fundamental picture remains unchanged: strong near-term earnings but an overextended valuation relative to the likely duration of scarcity.